Evidence map›Paper›PMID 35241504›Full record

ReviewIn vivo (Athens, Greece)

Prophylactic Radiotherapy of Hip Heterotopic Ossification: A Narrative Mini Review.

Erika Galietta, Luca Gaiani, Claudio Giannini, Andrea Sambri, Milly Buwenge, Gabriella Macchia, Francesco Deodato, Savino Cilla, Lidia Strigari, Michele Fiore and 3 more

Open access · diamondAbstract readReview
In one paragraph

Review in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review of the Pathogenesis, Diagnosis, and Management of Osteoradionecrosis of the Femoral Head.Medical science monitor : international medical journal of experimental and clinical research · 2023
    Article
  4. Review
  5. Non-Oncological Radiotherapy: A Review of Modern Approaches.Journal of personalized medicine · 2022
    Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Erika GaliettaRadiation Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Department of Experimental, Diagnostic and Specialty Medicine-DIMES, Alma Mater Studiorum University of Bologna, Bologna, Italy; erika.galietta@studio.unibo.it.
Luca GaianiU.O. Ortopedia e Traumatologia, AUSL Imola, Imola, Italy.
Claudio GianniniIRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
Andrea SambriUOC Ortopedia e Traumatologia, IRCCS Azienda Ospedaliera Universitaria di Bologna, Bologna, Italy.
Milly BuwengeRadiation Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Department of Experimental, Diagnostic and Specialty Medicine-DIMES, Alma Mater Studiorum University of Bologna, Bologna, Italy.
Gabriella MacchiaRadiation Oncology Unit, Gemelli Molise Hospital-Università Cattolica del Sacro Cuore, Campobasso, Italy.
Francesco DeodatoRadiation Oncology Unit, Gemelli Molise Hospital-Università Cattolica del Sacro Cuore, Campobasso, Italy.
Savino CillaMedical Physics Unit, Gemelli Molise Hospital-Università Cattolica del Sacro Cuore, Campobasso, Italy.
Lidia StrigariMedical Physics Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Michele FioreIRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
Silvia CammelliRadiation Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Department of Experimental, Diagnostic and Specialty Medicine-DIMES, Alma Mater Studiorum University of Bologna, Bologna, Italy.
Massimiliano De Paolis *UOC Ortopedia e Traumatologia, IRCCS Azienda Ospedaliera Universitaria di Bologna, Bologna, Italy.
Alessio Giuseppe Morganti *Radiation Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Department of Experimental, Diagnostic and Specialty Medicine-DIMES, Alma Mater Studiorum University of Bologna, Bologna, Italy.
University of Bologna · ITAzienda USL di Bologna · ITUniversità Cattolica del Sacro Cuore · ITIstituto Ortopedico Rizzoli · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Evidence on prophylactic radiotherapy (RT) in hip heterotopic ossification (HO) is sparse and conflicting. The aim of this literature review was to collect and summarize the available data on RT efficacy in preventing hip HO. The results of this review show that RT is effective in the prevention of hip HO, albeit with large variability across series. Effective prophylactic RT requires optimal treatment fields and time intervals with surgery. On the contrary, there is no clear evidence on the optimal timing (post-operative versus pre-operative RT). Comparisons between prophylactic RT and use of non-steroidal anti-inflammatory drugs showed conflicting results, although most were in favor of RT. In conclusion, RT is an established prophylactic treatment for hip HO. However, optimal dose, technique and timing remain unclear, as does the usefulness of combining RT with drugs.

Indexed as

Ossification, HeterotopicAnti-Inflammatory Agents, Non-SteroidalHumansPostoperative PeriodRadiotherapyRadiotherapy DosageAnti-Inflammatory Agents, Non-Steroidalheterotopic ossificationhipLiterature reviewprophylaxisradiotherapyreview

Identifiers

PMID35241504
PMCPMC8931919
OpenAlexW4214865215

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.